DUBLIN--(BUSINESS WIRE)--The "Dialysis Market by Dialysis Type, Products & Services, End User - Global Opportunity Analysis and Industry Forecast, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
The Global Dialysis Market size was valued to USD 105.58 billion in 2021, and is predicted to garner USD 145.85 billion by 2030, with a CAGR of 3.6% from 2022-2030.
Dialysis is a renal replacement therapy where excess water, salts, solutes, and toxins are removed from the blood of the patients whose kidneys do not perform these functions naturally. This is a blood purification procedure where toxins and excess fluids are removed from the body, thereby restoring the electrolyte balance of the blood.
Dialysis holds wide applications in treatment of chronic kidney diseases, acute renal injury, for those expecting a kidney transplant, or as a permanent measure where a transplant is not advisable. There are two types of dialysis such as Hemodialysis and Peritoneal Dialysis. Hemodialysis includes extra-corporeal purification of blood, whereas Peritoneal Dialysis includes blood purification by using peritoneum in the patient's abdomen for dialysis.
According to the National Kidney Foundation, 10% of the global population is affected by chronic kidney diseases; of which more than a million die each year due to lack of affordable treatments. This scenario has increased the penetration of dialysis treatment over the years, thereby supplementing the growth of the global dialysis market.
Additionally, increase in funding for better dialysis products and services, as well as growing number of patients suffering from end-stage renal disease (ESRD), further propagates the growth of dialysis market. The increasing prevalence of diabetes that initially affects kidney functioning is likely to positively impact the dialysis market size throughout the forecast period.
However, risks & complications associated with dialysis, and product recall may limit the growth of the dialysis market.
Furthermore, rising incidences of kidney failures, lack of kidney donors for transplantations, tedious kidney transplant procedures, and increasing demand for home peritoneal dialysis treatment shall create new opportunities for the growth of global dialysis market in the future.
Market Dynamics
Drivers
- Increasing Prevalence of Chronic Kidney Diseases (Ckd) Worldwide is Anticipated to Propel the Market Growth
- Rise in Research and Development Activities and Increasing New Product Approvals of Advanced Renal Care to Boost the Market Growth
Restraints
- High Cost of Dialysis Services Would Hamper Growth of the Dialysis Market
- Poor Reimbursement Policies and Lack of Awareness About the Available Treatment Options Restrict the Market Expansion
Opportunities
- Huge Unmet Need and Economic Development of the Developing Countries in Asia-Pacific and MEA Region Leverages Significant Growth Opportunities.
- Improved Healthcare Infrastructure and Growing Focus on the Effective Management of the Kidney Diseases Are Likely to Create Growth Opportunities
Key Market Segments:
Global Dialysis Market - By Dialysis Type
- Hemodialysis
- Short Daily Hemodialysis
- Conventional Hemodialysis
- Nocturnal Hemodialysis
- Peritoneal Dialysis
- Automated Peritoneal Dialysis (APD)
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
Global Dialysis Market - By Products & Services
- Equipment
- Dialysis Machines
- Water Treatment Systems
- Others
- Consumables
- Dialyzers
- Catheters
- Others
- Dialysis Drugs
- Services
Global Dialysis Market - By End User
- In-center Dialysis
- Home Dialysis
Global Dialysis Market - By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
- RoW
- Saudi Arabia
- South Africa
- Brazil
- Remaining Countries
Companies Mentioned
- Baxter International, Inc.
- DaVita Inc.
- Nikkiso Co. Ltd.
- NxStage Medical, Inc.
- Asahi Kasei Corporation
- Medicators, Inc
- Fresenius Medical Care AG & Co. KGaA
- Nipro Corporation
- B. Braun Avitum AG
- Diaverum Deutschland GmbH
For more information about this report visit https://www.researchandmarkets.com/r/oki5qh
